HCG Cancer Centre Mumbai – India's Dedicated Oncology Specialists

HCG Cancer Centre in Mumbai is a unit of Healthcare Global Enterprises (HCG), India's largest dedicated cancer care network with over 25 centres across the country. The Mumbai centre focuses exclusively on comprehensive oncology care—from diagnosis through treatment to survivorship—under one specialised roof, a model that has earned it recognition as one of India's most trusted cancer treatment destinations.

The centre's philosophy is driven by multidisciplinary collaboration: every patient case is reviewed by a tumour board that includes surgical oncologists, medical oncologists, radiation oncologists, pathologists and radiologists who arrive at a consensus treatment plan tailored to the individual's cancer type, stage and overall health. This rigorous process mirrors the standards of leading cancer centres in North America and Europe.

Radiation oncology is a particular strength. The centre operates advanced linear accelerators capable of delivering highly conformal radiotherapy techniques including Intensity Modulated Radiation Therapy (IMRT), Volumetric Modulated Arc Therapy (VMAT), Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiosurgery (SRS). These technologies allow oncologists to deliver curative-intent doses to tumours while maximally protecting surrounding healthy structures.

Medical oncology at HCG Mumbai covers the full spectrum of systemic therapies: conventional chemotherapy, targeted therapy using next-generation tyrosine kinase inhibitors, immunotherapy with checkpoint inhibitors, hormone therapy and antibody-drug conjugates—some of the newest classes of anti-cancer agents.

For patients travelling from the Gulf, East Africa and South Asia, HCG Mumbai offers a structured international patient programme. Coordinators assist with obtaining medical oncology visas, provide airport pick-up, arrange translations and support communication with referring oncologists in the patient's home country. Follow-up care is managed through the hospital's telemedicine platform.